RecruitingNot ApplicableNCT06237647

Comparison of Steroid, PRP,and PRP Plus Hyaluronic Acid Injection for Rotator Cuff Lesions.

Comparison of Steroid, Platelet-rich Plasma and Platelet-rich Plasma Plus Hyaluronic Acid Injection for Rotator Cuff Lesions


Sponsor

Tien-Ching Lee

Enrollment

80 participants

Start Date

Feb 17, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Rotator cuff tear is a common cause of shoulder pain. Steroids, hyaluronic acid (HA), and platelet-rich plasma (PRP) injections are becoming popular for the treatment of chronic rotator cuff partial tear. The investigators plan to evaluate the effect of the new product of PRP combined with HA on the rotator cuff and prove its benefit of pain control and function recovery.


Eligibility

Min Age: 20 YearsMax Age: 85 Years

Inclusion Criteria3

  • A. Shoulder pain for at least 1 months
  • B.partial-thickness tear diagnosed by MRI or Echo
  • C.age between 20 and 85 years old

Exclusion Criteria11

  • A. inflammatory disease, such as rheumatoid arthritis, SLE, etc.
  • B. pregnancy
  • C. known malignancy
  • D. hematologic disease (or hemoglobin <10 g/dl, platelet <150.000 ul)
  • E. history of shoulder infection
  • F. history of shoulder surgery
  • G. prior steroid injection for 3 times or more
  • H. full-thickness tear
  • I. other shoulder problems, such as osteoarthritis, fracture malunion, etc.
  • J. subjects who cannot comply with the protocol of study
  • K. The shoulder pain area has been treated with PRP for less than 3 months

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTHyaluronic acid, HA

improve tissue repair


Locations(1)

Kaohsiung Medical University Hospital

Kaohsiung City, Sanmin, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06237647